🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 12 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/10/2001 | 4,60 | 4,80 | 4,51 | 4,51 | -1,21% | 6,41% | 866.800 |
| 17/10/2001 | 5,20 | 5,20 | 4,50 | 4,56 | -9,25% | 13,47% | 1.616.600 |
| 16/10/2001 | 5,06 | 5,18 | 5,02 | 5,03 | +0,10% | 3,17% | 1.081.000 |
| 15/10/2001 | 5,32 | 5,67 | 4,88 | 5,02 | -38,63% | 14,96% | 5.629.600 |
| 12/10/2001 | 8,00 | 8,30 | 7,78 | 8,18 | +5,55% | 6,57% | 1.052.400 |
| 11/10/2001 | 7,12 | 8,07 | 7,00 | 7,75 | +12,24% | 14,97% | 1.322.000 |
| 10/10/2001 | 6,89 | 7,19 | 6,81 | 6,91 | +4,54% | 5,45% | 1.007.400 |
| 09/10/2001 | 6,54 | 6,66 | 6,54 | 6,61 | +0,46% | 1,84% | 310.400 |
| 08/10/2001 | 6,33 | 6,80 | 6,33 | 6,58 | +2,90% | 7,42% | 351.600 |
| 05/10/2001 | 6,37 | 6,49 | 6,25 | 6,39 | -0,62% | 3,77% | 147.800 |
| 04/10/2001 | 6,28 | 6,53 | 6,28 | 6,43 | +2,47% | 3,98% | 179.000 |
| 03/10/2001 | 6,38 | 6,38 | 6,03 | 6,28 | -1,57% | 5,49% | 542.000 |
| 02/10/2001 | 6,75 | 6,75 | 6,22 | 6,38 | -6,04% | 7,93% | 281.400 |
| 01/10/2001 | 6,28 | 7,00 | 6,22 | 6,79 | +8,04% | 12,43% | 401.800 |
| 28/09/2001 | 6,14 | 6,30 | 6,08 | 6,28 | +4,06% | 3,66% | 213.800 |
| 27/09/2001 | 5,73 | 6,16 | 5,41 | 6,04 | +5,23% | 13,10% | 266.800 |
| 26/09/2001 | 6,03 | 6,08 | 5,68 | 5,74 | -5,13% | 6,63% | 130.800 |
| 25/09/2001 | 6,11 | 6,13 | 5,84 | 6,05 | -1,23% | 4,67% | 166.400 |
| 24/09/2001 | 6,05 | 6,18 | 5,90 | 6,12 | +1,58% | 4,63% | 234.200 |
| 21/09/2001 | 5,93 | 6,10 | 5,78 | 6,03 | +0,67% | 5,49% | 590.800 |
| 20/09/2001 | 5,96 | 6,20 | 5,85 | 5,99 | -1,07% | 5,79% | 582.800 |
| 19/09/2001 | 6,01 | 6,20 | 5,83 | 6,05 | +0,75% | 6,24% | 672.600 |
| 18/09/2001 | 6,03 | 6,18 | 6,01 | 6,01 | -0,83% | 2,90% | 372.800 |
| 17/09/2001 | 6,32 | 6,32 | 5,83 | 6,06 | -4,42% | 7,76% | 207.200 |
| 10/09/2001 | 6,50 | 6,60 | 6,18 | 6,34 | -2,54% | 6,54% | 713.000 |
| 07/09/2001 | 6,65 | 6,70 | 6,29 | 6,50 | -4,27% | 6,17% | 188.800 |
| 06/09/2001 | 6,75 | 6,80 | 6,64 | 6,79 | +0,74% | 2,37% | 149.800 |
| 05/09/2001 | 6,86 | 6,86 | 6,65 | 6,74 | +0,45% | 3,06% | 117.600 |
| 04/09/2001 | 6,78 | 6,94 | 6,70 | 6,71 | -0,59% | 3,62% | 188.200 |
| 31/08/2001 | 6,82 | 6,96 | 6,75 | 6,75 | -1,46% | 3,08% | 246.400 |